Advertisement

International Journal of Colorectal Disease

, Volume 32, Issue 1, pp 135–138 | Cite as

The use of transureteroureterostomy during ureteral reconstruction for advanced primary or recurrent pelvic malignancy in the era of multimodal therapy

  • Junichiro KawamuraEmail author
  • Masaki Tani
  • Kimiaki Sumida
  • Takefumi Yazawa
  • Junya Kawasoe
  • Michihiro Yamamoto
  • Hideki Harada
  • Hidekazu Yamamoto
  • Masazumi Zaima
Short Communication
  • 128 Downloads

Abstract

Purpose

Cancerous involvement of a ureter is sometimes encountered in pelvic surgery for malignancy. We usually perform transureteroureterostomy (TUU) in cases of unilateral lower ureteral cancerous involvement. We report the outcomes in patients treated with TUU in our institute.

Methods

We retrospectively reviewed the medical records of 11 patients who underwent TUU between June 2006 and September 2015.

Results

The primary disease was colon cancer in five patients, rectal cancer in four, and uterine cervical cancer and ovarian cancer in one patient each. Early postoperative complications relevant to TUU occurred in four patients; however, three patients were managed conservatively and recovered quickly. Only one patient developed ureteral obstruction, which resulted from anastomotic hematoma. Follow-up periods ranged from 5 to 78 months with a median of 28 months. The median estimated glomerular filtration rate before and after TUU was 59 ml/min (range, 31–90 ml/min) and 62.0 ml/min (range, 43–127 mL/min), respectively. No patients experienced worsening of their renal function or recurrent urinary tract infection.

Conclusions

Short-term outcomes are good and long-term renal function is maintained following TUU. TUU is considered a feasible technique for ureteral reconstruction for pelvic malignancy, and TUU has great potential in the era of multimodal therapy.

Keywords

Colorectal neoplasms Pelvic malignancy Transureteroureterostomy Ureteral reconstruction 

Notes

Compliance with ethical standards

Funding

The authors declare that no funding support was received for this study.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

References

  1. 1.
    Joung JY, Jeong IG, Seo HK, Kim TS, Han KS, Chung J, Lee KH (2008) The efficacy of transureteroureterostomy for ureteral reconstruction during surgery for a non-urologic pelvic malignancy. J Surg Oncol 98:49–53. doi: 10.1002/jso.21086 CrossRefPubMedGoogle Scholar
  2. 2.
    Wells CA (1956) The use of the intestine in urology, omitting ureterocolic anastomosis. Br J Urol 28:335–350CrossRefPubMedGoogle Scholar
  3. 3.
    Armatys SA, Mellon MJ, Beck SD, Koch MO, Foster RS, Bihrle R (2009) Use of ileum as ureteral replacement in urological reconstruction. J Urol 181:177–181. doi: 10.1016/j.juro.2008.09.019 CrossRefPubMedGoogle Scholar
  4. 4.
    Iwaszko MR, Krambeck AE, Chow GK, Gettman MT (2010) Transureteroureterostomy revisited: long-term surgical outcomes. J Urol 183:1055–1059. doi: 10.1016/j.juro.2009.11.031 CrossRefPubMedGoogle Scholar
  5. 5.
    Pisters PW, Pettaway CA, Liu P, Matin SF, Ward JF, Leibovici D (2012) Is transureteroureterostomy performed during multi-organ resection for non-urothelial malignancy safe and effective? J Surg Oncol 106:62–65. doi: 10.1002/jso.23039 CrossRefPubMedGoogle Scholar
  6. 6.
    Strup SE, Sindelar WF, Walther MM (1996) The use of transureteroureterostomy in the management of complex ureteral problems. J Urol 155:1572–1574CrossRefPubMedGoogle Scholar
  7. 7.
    Sugarbaker PH, Gutman M, Verghese M (2003) Transureteroureterostomy: an adjunct to the management of advanced primary and recurrent pelvic malignancy. Int J Color Dis 18:40–44. doi: 10.1007/s00384-002-0399-2 CrossRefGoogle Scholar
  8. 8.
    Barry JM (2005) Surgical atlas transureteroureterostomy. BJU Int 96:195–201. doi: 10.1111/j.1464-410X.2005.05552.x CrossRefPubMedGoogle Scholar
  9. 9.
    Tanaka S, Martling A, Lindholm J, Holm T, Palmer G (2015) Remaining cancer cells within the fibrosis after neo-adjuvant treatment for locally advanced rectal cancer. Eur J Surg Oncol 41:1204–1209. doi: 10.1016/j.ejso.2015.05.019 CrossRefPubMedGoogle Scholar
  10. 10.
    Rainwater LM, Leary FJ, Rife CC (1991) Transureteroureterostomy with cutaneous ureterostomy: a 25-year experience. J Urol 146:13–15PubMedGoogle Scholar
  11. 11.
    Mure PY, Mollard P, Mouriquand P (2000) Transureteroureterostomy in childhood and adolescence: long-term results in 69 cases. J Urol 163:946–948CrossRefPubMedGoogle Scholar
  12. 12.
    Richter S, Kollmar O, Lindemann W, Schilling MK (2007) Transureteroureterostomy allows renal sparing radical resection of advanced malignancies with rectosigmoid invasion. Int J Color Dis 22:949–953. doi: 10.1007/s00384-006-0235-1 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Junichiro Kawamura
    • 1
    • 2
    Email author
  • Masaki Tani
    • 1
  • Kimiaki Sumida
    • 1
  • Takefumi Yazawa
    • 1
  • Junya Kawasoe
    • 1
  • Michihiro Yamamoto
    • 1
  • Hideki Harada
    • 1
  • Hidekazu Yamamoto
    • 1
  • Masazumi Zaima
    • 1
  1. 1.Department of Surgery, Shiga Medical Center for AdultsMoriyamaJapan
  2. 2.Department of Surgery, Faculty of MedicineKindai UniversityOsakaJapan

Personalised recommendations